• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

固体分散体冻干依法韦仑-聚乙烯吡咯烷酮K-30的制备与表征

Preparation and characterization of solid dispersion freeze-dried efavirenz - polyvinylpyrrolidone K-30.

作者信息

Fitriani Lili, Haqi Alianshar, Zaini Erizal

机构信息

Department of Pharmaceutics, Faculty of Pharmacy, Andalas University, Kampus Limau Manis, Padang, Indonesia.

出版信息

J Adv Pharm Technol Res. 2016 Jul-Sep;7(3):105-9. doi: 10.4103/2231-4040.184592.

DOI:10.4103/2231-4040.184592
PMID:27429930
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4932804/
Abstract

The aim of this research is to prepare and characterize solid dispersion of efavirenz - polyvinylpyrrolidone (PVP) K-30 by freeze drying to increase its solubility. Solid dispersion of efavirenz - PVP K-30 was prepared by solvent evaporation method with ratio 2:1, 1:1, and 1:2 and dried using a freeze dryer. Characterizations were done by scanning electron microscopy (SEM), powder X-ray diffraction analysis, differential thermal analysis (DTA), and Fourier transform infrared (FT-IR) spectroscopy. Solubility test was carried out in CO2-free distilled water, and efavirenz assay was conducted using high-performance liquid chromatography with acetonitrile:acetic acid (80:20) as the mobile phases. Powder X-ray diffractogram showed a decrease in the peak intensity, which indicated the crystalline altered to amorphous phase. DTA thermal analysis showed a decrease in the melting point of the solid dispersion compared to intact efavirenz. SEM results indicated the changes in the morphology of the crystal into an amorphous form compared to pure components. FT-IR spectroscopy analysis showed a shift wavenumber of the spectrum efavirenz and PVP K-30. The solubility of solid dispersion at ratio 2:1, 1:1, and 1:2 was 6.777 μg/mL, 6.936 μg/mL, and 14,672 μg/mL, respectively, whereas the solubility of intact efavirenz was 0.250 μg/mL. In conclusion, the solubility of solid dispersion increased significantly (P < 0.05).

摘要

本研究的目的是通过冷冻干燥制备依法韦仑-聚乙烯吡咯烷酮(PVP)K-30固体分散体并对其进行表征,以提高其溶解度。采用溶剂蒸发法,按照2:1、1:1和1:2的比例制备依法韦仑-PVP K-30固体分散体,并用冷冻干燥机进行干燥。通过扫描电子显微镜(SEM)、粉末X射线衍射分析、差示热分析(DTA)和傅里叶变换红外(FT-IR)光谱进行表征。在无二氧化碳的蒸馏水中进行溶解度测试,并使用乙腈:乙酸(80:20)作为流动相的高效液相色谱法进行依法韦仑含量测定。粉末X射线衍射图显示峰强度降低,这表明晶体转变为非晶相。DTA热分析表明,与完整的依法韦仑相比,固体分散体的熔点降低。SEM结果表明,与纯组分相比,晶体形态转变为无定形。FT-IR光谱分析显示依法韦仑和PVP K-30的光谱波数发生了偏移。比例为2:1、1:1和1:2的固体分散体的溶解度分别为6.777μg/mL、6.936μg/mL和14672μg/mL,而完整依法韦仑的溶解度为0.250μg/mL。总之,固体分散体的溶解度显著增加(P<0.05)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9e/4932804/9870695a1ae1/JAPTR-7-105-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9e/4932804/a3c757a05a05/JAPTR-7-105-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9e/4932804/183d55e3bc95/JAPTR-7-105-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9e/4932804/cf2aee9a1cf5/JAPTR-7-105-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9e/4932804/9870695a1ae1/JAPTR-7-105-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9e/4932804/a3c757a05a05/JAPTR-7-105-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9e/4932804/183d55e3bc95/JAPTR-7-105-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9e/4932804/cf2aee9a1cf5/JAPTR-7-105-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa9e/4932804/9870695a1ae1/JAPTR-7-105-g004.jpg

相似文献

1
Preparation and characterization of solid dispersion freeze-dried efavirenz - polyvinylpyrrolidone K-30.固体分散体冻干依法韦仑-聚乙烯吡咯烷酮K-30的制备与表征
J Adv Pharm Technol Res. 2016 Jul-Sep;7(3):105-9. doi: 10.4103/2231-4040.184592.
2
Influence of Milling Process on Efavirenz Solubility.研磨工艺对依非韦伦溶解度的影响
J Pharm Bioallied Sci. 2017 Jan-Mar;9(1):22-25. doi: 10.4103/0975-7406.206218.
3
The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.阿戈美拉汀在无定形固体分散体中的稳定性。 (注:原文中药物名称有误,正确的应该是“阿戈美拉汀”,而不是“佐匹克隆”,按照正确药物名翻译后的内容。如果按照错误药物名翻译就是:佐匹克隆在无定形固体分散体中的稳定性 )
AAPS PharmSciTech. 2015 Oct;16(5):1190-202. doi: 10.1208/s12249-015-0302-4. Epub 2015 Mar 4.
4
Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems.通过固体分散体系统进行依非韦伦的制剂开发及溶出速率提高
Indian J Pharm Sci. 2013 May;75(3):291-301. doi: 10.4103/0250-474X.117434.
5
Preparation, optimisation, and in vitro-in vivo evaluation of febuxostat ternary solid dispersion.非布司他三元固体分散体制备、优化及体内外评价。
J Microencapsul. 2018 Aug;35(5):454-466. doi: 10.1080/02652048.2018.1526339. Epub 2018 Dec 27.
6
Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.洛伐他汀与聚乙二醇4000和聚乙烯吡咯烷酮K30固体分散体的物理化学表征及溶出度研究
Pharm Dev Technol. 2007;12(1):21-33. doi: 10.1080/10837450601166510.
7
Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.吲哚美辛/PVP固体分散体肠溶微粒的拉曼光谱与热分析
Eur J Pharm Biopharm. 2008 Sep;70(1):409-20. doi: 10.1016/j.ejpb.2008.03.016. Epub 2008 Apr 8.
8
Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.他达拉非固体分散体的物理化学性质——聚合物对他达拉非表观溶解度和溶出速率的影响。
Eur J Pharm Biopharm. 2015 Aug;94:106-15. doi: 10.1016/j.ejpb.2015.04.031. Epub 2015 May 19.
9
Solubility and Physical Stability Enhancement of Loratadine by Preparation of Co-Amorphous Solid Dispersion with Chlorpheniramine and Polyvinylpyrrolidone.通过与氯苯那敏和聚乙烯吡咯烷酮制备共无定形固体分散体提高氯雷他定的溶解度和物理稳定性
Pharmaceutics. 2023 Oct 31;15(11):2558. doi: 10.3390/pharmaceutics15112558.
10
Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30.通过在聚乙烯吡咯烷酮K-30中形成美洛昔康的冻干固体分散体来提高其溶解速率和渗透速率。
Drug Dev Ind Pharm. 2006 Feb;32(2):141-50. doi: 10.1080/03639040500465983.

引用本文的文献

1
Preparation and evaluation of valsartan orodispersible tablets using PVP-K30 and HPMC E3 solid dispersions by the solvent evaporation method.采用溶剂蒸发法,使用聚乙烯吡咯烷酮K30(PVP-K30)和羟丙甲纤维素E3(HPMC E3)固体分散体制备缬沙坦口腔崩解片并进行评价。
Res Pharm Sci. 2025 Aug 25;20(4):566-579. doi: 10.4103/RPS.RPS_105_23. eCollection 2025 Aug.
2
Scope and Application of Hot Melt Extrusion in the Development of Controlled and Sustained Release Drug Delivery Systems.热熔挤出在控释和缓控释给药系统开发中的应用范围和应用。
Curr Pharm Des. 2024;30(32):2513-2523. doi: 10.2174/0113816128299356240626114734.
3
Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer.

本文引用的文献

1
Efavirenz dissolution enhancement I: co-micronization.依非韦伦溶出度增强 I:共微粉化。
Pharmaceutics. 2012 Dec 20;5(1):1-22. doi: 10.3390/pharmaceutics5010001.
2
Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems.通过固体分散体系统进行依非韦伦的制剂开发及溶出速率提高
Indian J Pharm Sci. 2013 May;75(3):291-301. doi: 10.4103/0250-474X.117434.
3
The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate.无定形固体分散体的应用:一种克服低溶解度和溶出速率的制剂策略。
无定形固体分散体作为癌症治疗中的药物递送载体
Polymers (Basel). 2023 Aug 11;15(16):3380. doi: 10.3390/polym15163380.
4
Superporous hydrogels based on blends of chitosan and polyvinyl alcohol as a carrier for enhanced gastric delivery of resveratrol.基于壳聚糖和聚乙烯醇共混物的超多孔水凝胶作为白藜芦醇增强胃递送载体
Saudi Pharm J. 2023 Mar;31(3):335-347. doi: 10.1016/j.jsps.2023.01.001. Epub 2023 Jan 5.
5
Thermodynamic Correlation between Liquid-Liquid Phase Separation and Crystalline Solubility of Drug-Like Molecules.类药物分子的液-液相分离与结晶溶解度之间的热力学相关性
Pharmaceutics. 2022 Nov 22;14(12):2560. doi: 10.3390/pharmaceutics14122560.
6
Proximate, Elemental, and Functional Properties of Novel Solid Dispersions of Leaf Powder.新型叶粉固体分散体的近程、元素和功能特性。
Molecules. 2022 Aug 3;27(15):4935. doi: 10.3390/molecules27154935.
7
Design, Manufacturing, Characterization and Evaluation of Lipid Nanocapsules to Enhance the Biopharmaceutical Properties of Efavirenz.用于增强依非韦伦生物制药特性的脂质纳米囊的设计、制造、表征及评价
Pharmaceutics. 2022 Jun 21;14(7):1318. doi: 10.3390/pharmaceutics14071318.
8
Effect of High-Energy Milling on the Dissolution of Anti-HIV Drug Efavirenz in Different Solvents.高能球磨对抗艾滋病病毒药物依非韦伦在不同溶剂中溶出度的影响
ACS Omega. 2021 May 3;6(19):12647-12659. doi: 10.1021/acsomega.1c00712. eCollection 2021 May 18.
9
Highly Water-Soluble Solid Dispersions of Honokiol: Preparation, Solubility, and Bioavailability Studies and Anti-Tumor Activity Evaluation.厚朴酚的高水溶性固体分散体:制备、溶解度、生物利用度研究及抗肿瘤活性评价
Pharmaceutics. 2019 Nov 1;11(11):573. doi: 10.3390/pharmaceutics11110573.
10
Influence of Milling Process on Efavirenz Solubility.研磨工艺对依非韦伦溶解度的影响
J Pharm Bioallied Sci. 2017 Jan-Mar;9(1):22-25. doi: 10.4103/0975-7406.206218.
Drug Discov Today Technol. 2012 Summer;9(2):e71-e174. doi: 10.1016/j.ddtec.2011.10.002.
4
Surface stabilized efavirenz nanoparticles for oral bioavailability enhancement.表面稳定的依非韦伦纳米粒以提高口服生物利用度。
J Biomed Nanotechnol. 2013 Nov;9(11):1862-74. doi: 10.1166/jbn.2013.1683.
5
Dissolution enhancement of efavirenz by solid dispersion and PEGylation techniques.通过固体分散体和聚乙二醇化技术提高依非韦伦的溶出度。
Int J Pharm Investig. 2011 Jan;1(1):29-34. doi: 10.4103/2230-973X.76726.
6
Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.依非韦伦-环糊精包合物的物理化学表征
AAPS PharmSciTech. 2009;10(1):81-7. doi: 10.1208/s12249-008-9180-3. Epub 2009 Jan 16.
7
Pharmaceutical applications of solid dispersion systems.固体分散体系统的药物应用。
J Pharm Sci. 1971 Sep;60(9):1281-302. doi: 10.1002/jps.2600600902.